<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:department>Warwick Medical School</gtr:department><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/73945564-B109-4D08-9AB9-725C388988DF"><gtr:id>73945564-B109-4D08-9AB9-725C388988DF</gtr:id><gtr:firstName>Jurgen</gtr:firstName><gtr:surname>Muller</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600790"><gtr:id>73DA0D3C-FD05-4FEE-868A-7C9AE26C2E15</gtr:id><gtr:title>Regulation of ERK Signalling by the Scaffold Protein KSR1</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600790</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The Ras GTPase is a critical regulator of cellular proliferation, differentiation and survival. A major route by which Ras transmits cellular signals is through the sequential activation of the protein kinases Raf-1, MEK and ERK. The outcome of signalling through this pathway is the translocation of activated ERK to the nucleus, where it phosphorylates a large number of proteins. This results in substantial changes in gene expression and ultimately progression through the G1 phase of the cell cycle.
Scaffold proteins provide spatial and temporal control to cellular signalling by directing associated proteins to specific compartments of the cell. In addition, they physically link several components of a pathway and can exclude others from the complex. Kinase Suppressor of Ras 1 (KSR1) is a conserved component of the Ras pathway that functions as a scaffold protein. It is dynamically regulated and has been found in the cytoplasm, at the plasma membrane, and in the nucleus. KSR1 enhances Ras signalling by linking Raf-1 and MEK at the plasma membrane, thereby facilitating the activation of MEK.
KSR1 also binds to activated ERK at the plasma membrane. However, the implications of this association for the signalling process are not well documented. In this proposal, we aim to characterise the role of the scaffold protein KSR1 in the regulation of ERK activity after growth factor stimulation of mammalian cells. These studies will provide new and substantial insight into the regulation of the MAPK signal transduction pathway. They will produce critical data regarding the regulation of ERK during mitogenic signalling and will emphasize the role of the scaffold protein KSR1 in this process.</gtr:technicalSummary><gtr:fund><gtr:end>2010-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>451222</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences</gtr:department><gtr:description>Neuronal MAPK Signalling</gtr:description><gtr:id>151FB04C-6126-4AF9-A2E3-27D4714FB6BB</gtr:id><gtr:impact>Multidisciplinary collaboration, combining expertise in cellular signalling with neuroscience.
Outputs (Publications): PMID: 21471251; PMID: 19861491; PMID: 25134715; PMID: 27296641; PMID: 27257628</gtr:impact><gtr:outcomeId>pLKLFuw4JmG-1</gtr:outcomeId><gtr:partnerContribution>This collaboration provides us access to neuroscience methods and equipment (e.g. electrophysiology and primary cell culture) as well as excellent expertise in neuroscience.</gtr:partnerContribution><gtr:piContribution>We contributed our expertise in MAPK signalling and biochemistry / cell biology as well as a number of biochemical techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MAPK Signalling in the cardiovascular system</gtr:description><gtr:id>2DAA0FBB-B80B-4B0A-989E-42A3C8C3357B</gtr:id><gtr:impact>Multi-disciplinary (Cell signalling and angiogenesis research)
Outputs (Publications):
PMID: 19909257
PMID: 20736307
PMID: 22800864
PMID: 25399574</gtr:impact><gtr:outcomeId>58b5495e850a40.19058031-1</gtr:outcomeId><gtr:partnerContribution>Our partners have provided expertise in cardiovascular research and techniques and provided reagents.</gtr:partnerContribution><gtr:piContribution>We contributed our expertise in the biochemistry of MAPK signalling and biochemical techniques. We also contributed a number of reagents to the collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>13CDE267-7259-4AF2-8D13-021EAB20290B</gtr:id><gtr:title>Negative feedback regulation of the ERK1/2 MAPK pathway.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/120281214fef9ef796e11f144d2a4771"><gtr:id>120281214fef9ef796e11f144d2a4771</gtr:id><gtr:otherNames>Lake D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>58b54588d1d327.56288179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80BB4036-CE19-4C3B-9C11-8672818B81C3</gtr:id><gtr:title>The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/240a27c7bd5d10365eaae398f59768ee"><gtr:id>240a27c7bd5d10365eaae398f59768ee</gtr:id><gtr:otherNames>Zhou L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>58b5455711c923.08767325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6E5D249-8341-49CC-B3CA-C3AC0956594E</gtr:id><gtr:title>Compartmentalization of the MAPK scaffold protein KSR1 modulates synaptic plasticity in hippocampal neurons.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6695c96544830f6ed3b8a17a6508dd5c"><gtr:id>6695c96544830f6ed3b8a17a6508dd5c</gtr:id><gtr:otherNames>Canal F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>mNEd7ME4U3W</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600790</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>